Safe Antibiotics and Anti-Emetics in Pregnancy

Safe Antibiotics in Pregnancy

The American College of Obstetricians and Gynecologists recommends penicillins, particularly amoxicillin, and cephalosporins, particularly cephalexin, as the safest first-line antibiotics for pregnant women, with decades of clinical experience demonstrating no teratogenic effects and compatibility throughout all trimesters and during breastfeeding 1
The European Respiratory Society suggests that penicillins are the preferred agents throughout pregnancy, with amoxicillin classified as Category A/B and compatible in all trimesters 2, 3, 1
The Centers for Disease Control and Prevention recommends ampicillin as an acceptable alternative to penicillin, particularly for Group B Streptococcus prophylaxis 4, 5, 6
The European Respiratory Society states that cephalosporins, such as cephalexin, cefuroxime, and ceftazidime, are safe throughout pregnancy with no demonstrated fetal harm 2, 3, 1, 7
The American College of Obstetricians and Gynecologists recommends cefazolin as the preferred agent for penicillin-allergic women without history of anaphylaxis 4, 8, 6

Antibiotics to Avoid

The European Respiratory Society advises that tetracyclines, such as doxycycline, should be avoided after the fifth week of pregnancy due to tooth discoloration, transient bone growth suppression, and potential maternal fatty liver 2, 3, 1
The European Respiratory Society recommends that trimethoprim-sulfamethoxazole should be avoided, especially during the first trimester, due to increased risk of preterm birth, low birthweight, kernicterus, hyperbilirubinemia, and fetal hemolytic anemia 2, 3, 1
The European Respiratory Society suggests that fluoroquinolones, such as ciprofloxacin, should be avoided due to potential fetal cartilage damage in animal studies 3
The European Respiratory Society advises that aminoglycosides, such as gentamicin and tobramycin, should be avoided if possible due to eighth cranial nerve toxicity and nephrotoxicity risk 2, 9

Infection-Specific Recommendations

The Centers for Disease Control and Prevention recommends penicillin G for Group B Streptococcus prophylaxis, with a dose of 5 million units IV initially, then 2.5-3.0 million units IV every 4 hours until delivery 4, 5, 8, 6, 1
The European Society of Cardiology suggests that penicillin, ampicillin, amoxicillin, erythromycin, mezlocillin, and cephalosporins can all be given during all trimesters for endocarditis treatment 10

Critical Clinical Pitfalls

The American College of Obstetricians and Gynecologists recommends screening all pregnant women for asymptomatic bacteriuria and Group B Streptococcus at 35-37 weeks gestation 1
The European Respiratory Society advises monitoring breastfed infants for gastrointestinal effects when the mother receives antibiotics 1
The European Respiratory Society suggests that antibiotics in breast milk may cause falsely negative cultures if a febrile infant requires evaluation 3, 1
The Centers for Disease Control and Prevention recommends that penicillin-allergic patients with a history of anaphylaxis, angioedema, respiratory distress, or urticaria should not receive penicillin, ampicillin, or cefazolin 4, 8, 6
The European Respiratory Society advises that amoxicillin-clavulanic acid is not recommended in women at risk of pre-term delivery due to a very low risk of necrotizing enterocolitis in the fetus 3

Guideline Recommendations for Antibiotic Use in Pregnancy

Safety Profile of Cephalosporins

Cephalosporins may be prescribed safely in any trimester of pregnancy, with no demonstrated fetal harm according to multiple international guidelines. 11
Penicillins and cephalosporins are classified among the safest antibiotic classes for pregnant and lactating women, showing compatibility throughout pregnancy and breastfeeding. 12
The cephalosporins with established safety records include cephalexin, cefuroxime, ceftazidime, and cefazolin. 11

First‑Line Clinical Indications

The European Respiratory Society recommends cephalosporins as first‑line empirical therapy for acute rhinosinusitis and acute exacerbations of chronic rhinosinusitis when endoscopic evidence of purulence is present. 12

Group B Streptococcus (GBS) Prophylaxis

The CDC (MMWR Recommendations and Reports) advises cefazolin 2 g IV as an initial dose, followed by 1 g IV every 8 hours until delivery for intrapartum GBS prophylaxis. 13

Penicillin Allergy Management

High‑risk penicillin allergy is defined as a history of anaphylaxis, angio‑edema, respiratory distress, or urticaria after penicillin or cephalosporin exposure; only these patients are considered high‑risk. [14][13]
For patients at high risk of anaphylaxis, cephalosporins—including cefazolin—should not be used. 13
In high‑risk patients, alternative agents such as clindamycin (if the GBS isolate is susceptible) or vancomycin are recommended. 13

Antibiotics to Avoid During Pregnancy

Tetracyclines (e.g., doxycycline) should be avoided after the fifth week of gestation because of risks of tooth discoloration, transient bone growth suppression, and potential maternal fatty liver disease. 11
Fluoroquinolones are contraindicated due to animal‑study evidence of potential fetal cartilage damage. [12][11]
Trimethoprim‑sulfamethoxazole should be avoided, especially in the first trimester, because of increased risks of preterm birth, low birthweight, kernicterus, hyperbilirubinemia, and fetal hemolytic anemia. 11
Aminoglycosides should be avoided when possible owing to risks of eighth cranial nerve toxicity and nephrotoxicity; they may be considered only as second‑line therapy in the second and third trimesters for severe infections. 11

Antibiotic Selection for Pregnant Women with Penicillin Allergy

Use of Cefixime in Non‑Severe Allergy

The CDC MMWR Recommendations and Reports state that cefixime can be prescribed to pregnant women who have a non‑severe penicillin allergy, but it should be avoided in those with a high‑risk penicillin allergy (e.g., anaphylaxis, angioedema, respiratory distress, or urticaria). Evidence level: expert recommendation based on observational safety data. 15

Preference for First‑Generation Cephalosporins When Allergy Is Not High‑Risk

According to the CDC MMWR Recommendations and Reports, for pregnant patients without high‑risk allergy features, first‑generation cephalosporins such as cefazolin or cephalexin are preferred over third‑generation agents like cefixime because they have a larger body of safety evidence. Evidence level: expert recommendation. 16

Alternative Agents for High‑Risk Penicillin Allergy

The CDC MMWR Recommendations and Reports advise that in pregnant women with high‑risk penicillin allergy, alternative antibiotics—such as clindamycin (if the pathogen is susceptible) or vancomycin—should be used instead of any cephalosporin, including cefixime. Evidence level: expert recommendation. 15

Safety and Recommendations for Amoxicillin‑Clavulanate Use in Pregnancy

Compatibility Classification

Specific Contraindications

Cephalexin Use in Pregnancy: Safety and Guideline Recommendations

Safety Evidence

Cephalexin is safe during the first trimester of pregnancy, with moderate‑quality evidence showing no increase in congenital malformations or adverse fetal outcomes. The evidence is drawn from pooled data in the 2025 Journal of the American Academy of Dermatology. 18

Guideline Recommendations

2025 North American guidelines for hidradenitis suppurativa recommend oral cephalexin as a preferred systemic antibiotic for pregnant patients, citing moderate‑quality evidence for its safety in the first trimester. This recommendation applies to women requiring systemic therapy for hidradenitis suppurativa. [18][19]
For pregnant patients with hidradenitis suppurativa, cephalexin is suggested alongside azithromycin and clindamycin as first‑line systemic agents, each supported by moderate‑quality evidence. The recommendation appears in the same 2025 dermatology guideline. 18

Contraindicated Antibiotics in Pregnancy

Doxycycline and other tetracyclines are strongly contraindicated in pregnancy because they cause fetal tooth discoloration, transient bone growth suppression, and may induce maternal hepatic toxicity. This contraindication is highlighted in the 2025 Journal of the American Academy of Dermatology. 18
Trimethoprim‑sulfamethoxazole should be avoided, especially in the first trimester, due to increased risks of preterm birth, low birthweight, kernicterus, and fetal hemolytic anemia. Evidence is reported in the 2025 Journal of the American Academy of Dermatology. 18
Metronidazole is not recommended during pregnancy because it may raise the risk of low birthweight and neuroblastoma in the offspring. The risk assessment is cited in the 2025 Journal of the American Academy of Dermatology. 18
Erythromycin is associated with elevated maternal liver enzymes and adverse pregnancy outcomes and should be avoided. This safety concern is documented in the 2025 Journal of the American Academy of Dermatology. 18

Antibiotic Management of Bacterial Bronchitis in Mid‑Gestation Pregnancy

First‑Line Antibiotic Recommendation

Amoxicillin is the reference antibiotic for respiratory tract infections in pregnant patients, classified as Category A/B with documented safety across all trimesters – recommended as the first‑line agent for bacterial bronchitis at 22 weeks gestation. 20

Pathogen Coverage

Beta‑lactam antibiotics, including amoxicillin, provide effective coverage of the common bronchitis pathogens Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis – ensuring adequate antimicrobial activity without teratogenic risk. 20
Amoxicillin specifically offers excellent activity against S. pneumoniae and the majority of H. influenzae strains, making it suitable for empiric therapy in this population. 20

Dosing and Duration

Standard adult dosing of amoxicillin (500 mg three times daily or 875 mg twice daily) is appropriate for pregnant patients, with no routine need for dose escalation at 22 weeks gestation. 20
A treatment course of 10–14 days is recommended to achieve complete bacterial eradication and minimise recurrence risk in pregnant women with bronchitis. 20

Diagnostic Criteria and Treatment Algorithm

Bacterial bronchitis should be confirmed by the presence of purulent sputum, fever > 38 °C lasting > 3 days, or clinical worsening despite supportive care before initiating antibiotics. [20][21]
First‑line therapy is amoxicillin 500 mg three times daily for 10–14 days in confirmed cases. 20
If no clinical improvement is observed within 48–72 hours, reassessment is required to consider resistant organisms or alternative diagnoses. [20][21]

Risks of Delaying Therapy

Untreated respiratory infections pose a greater fetal risk through maternal hypoxia than the potential adverse effects of appropriate antibiotic therapy, underscoring the importance of not withholding antibiotics solely because of pregnancy. 22